|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Fetal Fibronectin
MessageRapid fFN Specimen Collection Kit must be used
Test Code
FETFIB
CPT Codes
82731
Preferred Specimen
Rapid fFN Swab

Other Acceptable Specimens
NONE
Transport Container
Rapid fFN Swab
Transport Temperature
Room Temperature
Specimen Stability
Room Temperature: 8 hours; Refrigerated: 3 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Specimens not collected using Rapid fFN Specimen Collection Kit
Limitations
Specimens for fetal fibronectin testing should be collected prior to collection of culture specimens; Specimens should be obtained prior to digital cervical examination of vaginal probe ultrasound examination as manipulation of the cervix may cause the release of fetal fibronectin; Specimens should not be tested if the patient has had sexual intercourse within 24 hours prior to the sampling time because semen and/or sperm present in the sample may increase the possibility of a false positive result; Care must be taken not to contaminate the swab or cervicovaginal secrections with lubricants, soaps, disinfectants or creams (e.g., K-Y Jelly lubricant, Betadine disinfectant, Moistat cream, hexachlorophene; Not intended for use in women with moderate or gross vaginal bleeding. Bloody specimens can lead to false positive results; Rupture of membranes should be ruled out prior to specimen collection since fetabl fibronectin is found in both amniotic fluid and fetal membranes
Clinical Significance
The Rapid fFN test is to be used as an aid in assessing the risk of preterm delivery in less than or equal to 7 or 14 days from the time of cervicovaginal sample collection in pregnant women with signs and symptoms of early preterm labor, intact amniotic membranes and minimal cervical dilatation (< 3 cm), sampled between 24 weeks, 0 days and 34 weeks, 6 days gestation. 2. The Rapid fFN test is further indicated for use in conjunction with other clinical information as an aid in assessing the risk of preterm delivery in less than or equal to 34 weeks, 6 days when a cervicovaginal sample is obtained during a routine prenatal visit between 22 weeks, 0 days and 30 weeks, 6 days of gestation in women with a singleton pregnancy.
Performed By
RFGH Laboratory
Performing Laboratory
RFGH Laboratory

